ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ACOR Acorda Therapeutics Inc

0.661
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.661 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.661
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/15/202417:03BWAcorda Therapeutics Announces Delisting from Nasdaq
4/03/202417:30BWAcorda Therapeutics Announces Nasdaq Delisting Notification
4/01/202418:35BWAcorda Therapeutics and Merz Announce Signing of “Stalking..
4/01/202416:01BWAcorda Cancels Q4 and Year End 2023 Earnings Conference Call..
3/25/202416:01BWAcorda Fourth Quarter/Year End 2023 Update:..
1/11/202408:33EDGAR2Form 8-K - Current report
1/11/202408:01BWAcorda Therapeutics to Regain Global Commercialization..
12/01/202316:30EDGAR2Form 8-K - Current report
11/13/202316:16EDGAR2Form 8-K - Current report
11/13/202316:01BWAcorda Therapeutics Reports Third Quarter 2023 Financial..
11/06/202316:01BWAcorda Third Quarter 2023 Update: Webcast/Conference Call..
11/06/202308:00BWAcorda Therapeutics Announces Biopas Laboratories Submission..
8/08/202316:12EDGAR2Form 8-K - Current report
8/08/202316:01BWAcorda Therapeutics Reports Second Quarter 2023 Financial..
8/02/202308:00BWAcorda Therapeutics Announces Launch of New INBRIJA®..
8/01/202308:00BWAcorda Second Quarter 2023 Update: Webcast/Conference Call..
6/28/202317:08BWTom Burns Elected to the Acorda Therapeutics Board of..
6/26/202308:23BWAcorda Therapeutics Regains Compliance with Nasdaq Minimum..
6/26/202308:00BWAcorda Therapeutics Regains Compliance with Nadaq Minimum..
6/02/202316:01BWAcorda Therapeutics Announces Completion of 1-for-20 Reverse..
5/31/202316:01BWAcorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
5/30/202308:00BWAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual..
5/11/202316:01BWAcorda Therapeutics Reports First Quarter 2023 Financial..
5/10/202307:00BWAcorda Therapeutics to Make June 2023 $6.2 Million Interest..
5/08/202307:00BWAcorda Therapeutics and Chance Pharmaceuticals Announce..
5/04/202309:41BWAcorda First Quarter 2023 Update: Webcast/Conference Call..

Your Recent History

Delayed Upgrade Clock